Search results
RSV research: Nirsevimab 80% effective against hospitalization
Center for Infectious Disease Research and Policy· 7 days agoTwo studies highlight new respiratory syncytial virus (RSV) findings, with one estimating that the ...
Future of Chromatography Resins: Improved Resolution in Bioprocessing, Upcoming Webinar Hosted by...
PRWeb· 1 day agoChromatography resins are crucial in the purification process of biotherapeutic products, including everything from monoclonal antibodies to cell and gene therapies. With increase in the awareness ...
AbbVie inks deal potentially worth $1.7 billion for new IBD drug
Crain s Chicago Business· 1 day agoAbbVie's latest move in inflammatory bowel disease treatments is a licensing agreement to develop a next generation antibody engineered by Beijing-based FutureGen. The terms of the deal call ...
Dianthus receives FDA greenlight to begin Phase II trial in MMN
Clinical Trials Arena via Yahoo Finance· 2 days agoInitial top-line results are slated for the second half of 2026, according to the US biotech....
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...
FOX40 Sacramento· 15 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Dr. Jeff Hersh addresses cause, effects and complications of Graft vs Host Disease
The Metrowest Daily News via Yahoo News· 6 days agoGraft vs Host Disease occurs when white blood cells produced by donated stem cells identify the...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
WKBT La Crosse· 4 days agoDonanemab works by helping the body remove amyloid plaque buildups in the brain that are a hallmark...
Is 'Difficult-to-Treat' RA a Lost Cause?
MedPage Today· 1 day agoRheumatologists are still struggling with what to do when multiple state-of-the-art treatments have failed to bring rheumatoid arthritis (RA) under...
Infusions for psoriatic arthritis: Purpose, medications, benefits
Medical News Today· 2 days agoInfusion therapy for psoriatic arthritis (PsA) involves administering medications known as biologics...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
AOL· 1 day agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of blockbuster arthritis drug Humira following the entry of biosimilars in the U.S. The drugmaker ...
